10.2174/1381612811319190006 75 Jablonski-MomeniA.Korbmacher-SteinerH.Heinzel-GutenbrunnerM.JablonskiB.JaquetW.BottenbergP
XTALKS WEBINAR: Sarcopenia: Changes and Challenges in Body Composition with GLP-1 Receptor Agonist-based Weight Loss Therapies Live and On-Demand: Friday, September 6, 2024 , at 10am EDT (4pm CEST / EU-Central) Register for this free webinar to learn about the latest clinical trial data on GLP-1 receptor agonist-based therapies and their impact on weight loss and body composition
If a patient fails to consume adequate amounts of high biological value proteins and experiences significant protein loss through dialysis, the body begins to catabolize muscle tissue to meet its protein requirements
FortierMCastellanoC-ACroteauELangloisFBoctiCSt-PierreVet al
Gonzlez-Molina V, Mart-Pineda A, Gonzlez N
However, moderation is key